Your browser doesn't support javascript.
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.
Hassan, Sk Sarif; Attrish, Diksha; Ghosh, Shinjini; Choudhury, Pabitra Pal; Uversky, Vladimir N; Aljabali, Alaa A A; Lundstrom, Kenneth; Uhal, Bruce D; Rezaei, Nima; Seyran, Murat; Pizzol, Damiano; Adadi, Parise; Soares, Antonio; Abd El-Aziz, Tarek Mohamed; Kandimalla, Ramesh; Tambuwala, Murtaza M; Azad, Gajendra Kumar; Sherchan, Samendra P; Baetas-da-Cruz, Wagner; Lal, Amos; Palù, Giorgio; Takayama, Kazuo; Serrano-Aroca, Ángel; Barh, Debmalya; Brufsky, Adam M.
  • Hassan SS; Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram 721140, India. Electronic address: sarimif@gmail.com.
  • Attrish D; Dr. B. R. Ambedkar Centre For Biomedical Research (ACBR), University of Delhi (North Campus), Delhi 110007, India.
  • Ghosh S; Department of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, Kolkata 700009, West Bengal, India.
  • Choudhury PP; Applied Statistics Unit, Indian Statistical Institute, Kolkata 700108, West Bengal, India.
  • Uversky VN; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA. Electronic address: vuversky@usf.edu.
  • Aljabali AAA; Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University-Faculty of Pharmacy, Irbid 566, Jordan. Electronic address: alaaj@yu.edu.jo.
  • Lundstrom K; PanTherapeutics, Rte de Lavaux 49, CH1095 Lutry, Switzerland.
  • Uhal BD; Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
  • Rezaei N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Stockholm, Swed
  • Seyran M; Doctoral Studies in Natural and Technical Sciences (SPL 44), University of Vienna, Austria.
  • Pizzol D; Italian Agency for Development Cooperation - Khartoum, Sudan Street 33, Al Amarat, Sudan.
  • Adadi P; Department of Food Science, University of Otago, Dunedin 9054, New Zealand. Electronic address: parise.adadi@postgrad.otago.ac.nz.
  • Soares A; Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229-3900, USA. Electronic address: soaresa@uthscsa.edu.
  • Abd El-Aziz TM; Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229-3900, USA; Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt. Electronic address: mohamedt1@uthscsa.edu.
  • Kandimalla R; CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India; Department of Biochemistry, Kakatiya Medical College, Warangal, Telangana State, India. Electronic address: ramesh.kandimalla@iict.res.in.
  • Tambuwala MM; School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK. Electronic address: m.tambuwala@ulster.ac.uk.
  • Azad GK; Department of Zoology, Patna University, Patna 800005, Bihar, India. Electronic address: gkazad@patnauniversity.ac.in.
  • Sherchan SP; Department of Environmental Health Sciences, Tulane University, New Orleans, LA 70112, USA. Electronic address: sshercha@tulane.edu.
  • Baetas-da-Cruz W; Translational Laboratory in Molecular Physiology, Centre for Experimental Surgery, College of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • Lal A; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Palù G; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121 Padova, Italy. Electronic address: giorgio.palu@unipd.it.
  • Takayama K; Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8397, Japan. Electronic address: kazuo.takayama@cira.kyoto-u.ac.jp.
  • Serrano-Aroca Á; Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia, San Vicente Mártir 46001, Valencia, Spain. Electronic address: angel.serrano@ucv.es.
  • Barh D; Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Purba Medinipur, India.
  • Brufsky AM; University of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: brufskyam@upmc.edu.
Int J Biol Macromol ; 181: 801-809, 2021 Jun 30.
Article in English | MEDLINE | ID: covidwho-1188606
ABSTRACT
The current Coronavirus Disease 19 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) shows similar pathology to MERS and SARS-CoV, with a current estimated fatality rate of 1.4%. Open reading frame 10 (ORF10) is a unique SARS-CoV-2 accessory protein, which contains eleven cytotoxic T lymphocyte (CTL) epitopes each of nine amino acids in length. Twenty-two unique SARS-CoV-2 ORF10 variants have been identified based on missense mutations found in sequence databases. Some of these mutations are predicted to decrease the stability of ORF10 in silico physicochemical and structural comparative analyses were carried out on SARS-CoV-2 and Pangolin-CoV ORF10 proteins, which share 97.37% amino acid (aa) homology. Though there is a high degree of ORF10 protein similarity of SARS-CoV-2 and Pangolin-CoV, there are differences of these two ORF10 proteins related to their sub-structure (loop/coil region), solubility, antigenicity and shift from strand to coil at aa position 26 (tyrosine). SARS-CoV-2 ORF10, which is apparently expressed in vivo since reactive T cell clones are found in convalescent patients should be monitored for changes which could correlate with the pathogenesis of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Nonstructural Proteins / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Int J Biol Macromol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Nonstructural Proteins / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Int J Biol Macromol Year: 2021 Document Type: Article